HEALTH CARE
https://aseestant.ceon.rs/index.php/zdravzast
<p>Scientific journal <strong>Zdravstvena zaštita </strong>(journal <strong><em>Health care</em></strong>), which is published by the Chamber of health institution of Serbia since 1972, publishes unpublished original expert and scientific papers, review articles, short announcements, introductions, letters to the editor, meta – analysis, depictions of the patients, current topics, depictions of scientific books and conferences, among other things related to the field of medicine, stomatology, pharmacology, biochemistry and health management. In this way, the magazine contributes to promotion and development of science, as well as expertise and scientific and research work.</p> <p>Most preeminent experts of different profiles and with different scientific titles publish their scientific and research papers in the journal. By means of conveying the selected texts, the pages of <strong>Health care </strong>represent the testimony, of both the pioneering work of the Chamber, and a kind of history of health care in Serbia alike.</p> <p>Electronic publishing of the journal <strong>Health care </strong>has been conducted since January 2019, and it is available in the regime of open access since September 2019. Open access enables reading free of charge, downloading, saving, printing and using writings published in the journal to any user that has an internet access. All papers published in <strong>Health care </strong>can be downloaded for free on the journal’s website:</p> <p>www.komorazus.org.rs/jurnal. The journal is published four times a year.</p> <p>Prior to publishing in <strong>Health care</strong>, all writings are subject of an internal review (preliminary review of the writing by the editor and/or editorial board) as well as an external review (independent reviews by the experts form the given field, while respecting the anonymity of the author of the review and the author of the paper). Final decision on whether the paper is going to be published is reached on the basis of expertly, ethical, and statistical review. Control for plagiarism is performed before the paper is published, which implies comparing the manuscript to all original texts in the available databases.</p> <p>Papers must be written in the English language, with summaries in both Serbian and English languages, and in the transitional period, until September of 2020, in Serbian and English languages, with summaries in Serbian and English languages.</p> <p>Papers published in the journal <strong>Health care </strong>are indexed by: SCIndeks - Serbian Citation Index, COBISS.SR – ID 3033858 and doi Serbia.</p>KOMORA ZDRAVSTVENIH USTANOVA SRBIJEsr-RS@latinHEALTH CARE0350-3208GLOBAL GEOGRAPHY OF INFECTIVE ENDOCARDITIS PATHOGENS: ETIOLOGY AND RESISTANCE IN THE 21ST CENTURY
https://aseestant.ceon.rs/index.php/zdravzast/article/view/67159
<p class="MsoNormal" style="margin-bottom: .0001pt; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Introduction/Aim:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> The etiology of infective endocarditis is diverse and complex. It varies significantly depending on geographical region, socioeconomic conditions, healthcare availability, and the prevalence of predisposing factors. The aim of this paper is to analyze the global geographical distribution of infective endocarditis pathogens in the 21st century, focusing on regional differences in etiology, diagnostics, therapy, and antimicrobial resistance.</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Methods:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> A secondary data analysis was conducted. Descriptive statistics were used to quantify pathogen frequency, the prevalence of resistant strains, and regional etiological differences.</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Results:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> In developed regions (North America and Western Europe), <em>Staphylococcus aureus</em> predominates, often associated with healthcare settings (30–35%) and high rates of MRSA resistance (up to 28%). Conversely, in developing countries, streptococci remain more prevalent, alongside the persistence of rheumatic heart disease. The availability of transesophageal echocardiography (TEE) and surgical treatment is significantly higher in developed countries, which directly contributes to a lower mortality rate (14–15%) compared to resource-limited regions (22%).</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Conclusion:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> Infective endocarditis has evolved into a disease associated with modern medicine and aging populations in developed countries, while in the rest of the world, it remains strongly associated with low socioeconomic conditions. High mortality and increasing resistance necessitate the global standardization of diagnostics and locally adapted therapeutic strategies.</span></p>Saška Trnkić AndrejevićTatjana RistićDejan ČučulanovićSnežana Ćirić ZdravkovićDesa Nastasijević Borovac
Copyright (c) 2026 HEALTH CARE
2026-05-292026-05-2955110.5937/zdravzast55-67159DARIER DISEASE –A RETROSPECTIVE SERIES OF 67 CASES
https://aseestant.ceon.rs/index.php/zdravzast/article/view/65143
<p><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG/> </o:OfficeDocumentSettings> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves/> <w:TrackFormatting/> <w:PunctuationKerning/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> <w:DontGrowAutofit/> <w:SplitPgBreakAndParaMark/> <w:EnableOpenTypeKerning/> <w:DontFlipMirrorIndents/> <w:OverrideTableStyleHps/> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="--"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" Priority="39" Name="toc 1"/> <w:LsdException Locked="false" Priority="39" Name="toc 2"/> <w:LsdException Locked="false" Priority="39" Name="toc 3"/> <w:LsdException Locked="false" Priority="39" Name="toc 4"/> <w:LsdException Locked="false" Priority="39" Name="toc 5"/> <w:LsdException Locked="false" Priority="39" Name="toc 6"/> <w:LsdException Locked="false" Priority="39" Name="toc 7"/> <w:LsdException Locked="false" Priority="39" Name="toc 8"/> <w:LsdException Locked="false" Priority="39" Name="toc 9"/> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/> </w:LatentStyles> </xml><![endif]--><!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} </style> <![endif]--></p> <p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Introduction/Aim:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> Darier disease is a rare autosomal dominant genodermatosis caused by mutations in the ATP2A2 gene and characterized by distinct clinical and histopathological findings. The aim of this study was to present the epidemiological and therapeutic characteristics of patients with Darier disease treated at a tertiary care center over a fifteen-year period.</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Methods:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> A retrospective cohort study including 67 patients diagnosed with Darier disease and treated at the Clinic of Dermatovenereology, University Clinical Center of Serbia, Belgrade, Republic of Serbia, was conducted. The diagnosis was established based on characteristic clinical presentation and histopathological confirmation. Epidemiological, clinical, and therapeutic characteristics were analyzed.</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Results:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> Female predominance (66%) was observed in the study population, while the first skin lesions most commonly appeared during adolescence and early adulthood. Positive family history was recorded in 48% of patients, supporting the autosomal dominant inheritance pattern. Lesions were predominantly localized on the trunk (85%). Neuropsychiatric comorbidities were observed in 16% of patients. Topical therapy was used in all patients, whereas systemic retinoids were administered in 51% of patients, predominantly in generalized forms of the disease.</span></p> <p style="line-height: 115%;" data-start="2288" data-end="2560"> </p> <p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Conclusion:</span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;"> The results highlight the chronic course of the disease, marked phenotypic variability, and the need for individualized therapeutic approaches.</span></p> <p> </p>Nađa NiševićAleksandra NikolićMilica MihajlovićDušan ElbourshDražen Radanović
Copyright (c) 2026 HEALTH CARE
2026-05-292026-05-2955110.5937/zdravzast55-65143PROBIOTIC SUPPLEMENTATION FOR THE RESTORATION OF INTESTINAL MICROBIOTA IN NEWBORNS BORN BY CESAREAN SECTION
https://aseestant.ceon.rs/index.php/zdravzast/article/view/65136
<p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">The early establishment of intestinal microbiota in newborns is significantly disrupted in children born by cesarean section, characterized by the absence of beneficial anaerobic bacteria and an increased proportion of opportunistic microorganisms. This initial dysbiosis is associated with an increased risk of allergies, infections, and other immune imbalances. Probiotic supplementation represents a strategy to correct these disorders. The use of specific strains, particularly from the genera Lactobacillus and Bifidobacterium, can accelerate the colonization of the intestinal microbiota to resemble that of vaginally born children. These probiotics modulate the immune response, reducing the Th2 profile and promoting anti-inflammatory signals, while simultaneously strengthening the intestinal barrier and enhancing the production of short-chain fatty acids. Clinical data indicate positive effects, including a reduction in gastrointestinal complaints and the incidence of necrotizing enterocolitis in preterm infants, as well as improved immune markers. The mechanisms of action include competition for resources, production of bacteriocins, and interaction with immune cells. Although existing evidence supports the potential of probiotics in restoring the microbiota, variability in studies highlights the need for long-term monitoring and standardized protocols to fully assess health outcomes in this population.</span></p>Ivana StepanovićJovana Radovanović
Copyright (c) 2026 HEALTH CARE
2026-05-292026-05-2955110.5937/zdravzast55-65136NUTRITIONAL INTERVENTIONS AND COGNITIVE OUTCOMES IN CHILDREN FROM TWO TO SIX YEARS OF LIFE
https://aseestant.ceon.rs/index.php/zdravzast/article/view/65347
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;"><span lang="SR-LATN-RS" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-ansi-language: SR-LATN-RS;">The development of cognitive abilities in children aged 2 to 6 years is significantly influenced by nutritional status. This research examines the effectiveness of nutritional interventions that depend on biological, social, and educational factors. Prenatal supplementation and higher maternal education are associated with more favorable cognitive outcomes, while children born with low birth weight show longer-lasting delays. The effectiveness of interventions varies. Multinutrient supplementation with five or more nutrients demonstrates a broader impact on cognitive functions compared to targeted supplementation. The period between 6 and 18 months of age is particularly important for the implementation of intervention programs. Integrating nutritional support with educational approaches that include structured play and physical activity can promote the parallel development of motor and cognitive skills. Methodological challenges include the need for randomized controlled trials, longer follow-up periods, and the use of laboratory biomarkers to assess nutrient status. Results indicate that the effects of interventions depend on the initial nutritional and health status of the child, the duration of treatment, and the social context. Recommendations for future work include expanding research to rural populations and children with special needs, standardizing measurement methods, and conducting long-term monitoring to assess the sustainability of benefits. This holistic approach emphasizes the importance of coordination between the health and education sectors to enhance cognitive development.</span></p>Ivana StepanovićJovana Radovanović
Copyright (c) 2026 HEALTH CARE
2026-05-292026-05-2955110.5937/zdravzast55-65347PAIN MEDICINES WITH SPECIAL REFERENCE TO TRAMADOL
https://aseestant.ceon.rs/index.php/zdravzast/article/view/66674
<p style="margin: 0cm; margin-bottom: .0001pt; text-align: justify; line-height: 150%;">Pain represents a significant medical and social problem because it affects daily functioning, as well as psychological, emotional and social well-being, causing significant economic and health problems. Pain control is one of the main goals of modern medicine, and the drugs used for this purpose are called analgesics. There is no one-size-fits-all medicine for every type of pain. That is why an individual approach to each patient is of key importance for the treatment and prevention of the recurrence of the disease. The aim is to demonstrate that the use of tramadol in relieving and reducing pain, with clearly defined indications, strictly controlled administration,<span style="mso-spacerun: yes;"> </span>precisely determined dosage and limited duration of use, can be an effective therapeutic option for the treatment of moderate and moderately severe pain when first-line medications are insufficiently effective or contraindicated. "The medicine is both medicine and poison at the same time!" When it is used according to the indications and instructions, it exerts its positive effect, and in the second case, when the indications, therapeutic doses, time intervals and length of therapy are not followed, it then exerts its negative effect. Healthcare professionals are required to assess the risk of addiction before starting therapy.</p>Tatjana RistićMaja BabićSaša VučetićSaška Trnkić Andrejević4
Copyright (c) 2026 HEALTH CARE
2026-05-292026-05-2955110.5937/zdravzast55-66674VOICE AND SPEECH IN PARKINSON'S DISEASE: CLINICAL CHARACTERISTICS OF HYPOKINETIC DYSPHONIA
https://aseestant.ceon.rs/index.php/zdravzast/article/view/64015
<p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><span style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt;">Parkinson's disease is a chronic, progressive neurodegenerative disease that is primarily manifested by motor disorders, but significantly affects voice and speech. One of the frequent and clinically significant manifestations of the disease is hypokinetic dysphonia, which occurs as a result of central dopaminergic deficit and hypokinesia of muscles involved in respiration, phonation and articulation. The aim of this review is to present the basic neurological and clinical characteristics of Parkinson's disease, the mechanisms of hypokinetic dysphonia, as well as the voice, speech and paralinguistic characteristics of patients with this disease, while considering the implications for clinical and speech therapy practice. The search for relevant sources was carried out using Google Scholar Advanced Search and the Consortium of Libraries of Serbia for Unified Procurement (KoBSON), where modern sources from the fields of neurology, phoniatrics and speech therapy were analyzed. The results of the review indicate that voice and speech disorders, including hypophonia, monotony, reduced intonation variation and disorganized prosody, significantly impair communication and the quality of life of sufferers. Paralinguistic communication deficits, which contribute to the social isolation of patients, are especially pronounced. It is concluded that timely recognition of hypokinetic dysphonia and an interdisciplinary approach, along with active involvement in speech therapy treatment, is of key importance for preserving communication skills and improving the overall functioning of people with Parkinson's disease.</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; text-align: justify; line-height: 150%;"> </p>Ivana Ilic SavicMirjana Petrović-LazićSnežana Babac
Copyright (c) 2026 HEALTH CARE
2026-05-292026-05-2955110.5937/zdravzast55-64015THE IMPLEMENTATION OF THE NURSING PROCESS IN A PERSON WITH MENTAL HEALTH PROBLEMS: A CASE REPORT
https://aseestant.ceon.rs/index.php/zdravzast/article/view/63101
<p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Introduction/Aim</span></strong><strong style="mso-bidi-font-weight: normal;"><span lang="SR-LATN-RS" style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif; mso-ansi-language: SR-LATN-RS;">:</span></strong> <span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">The <span style="mso-bidi-font-weight: bold;">Nursing Process (NP)</span> represents a fundamental, systematic, and individualized method of work in nursing that enables a holistic approach to the patient. Its application is of particular importance in psychiatric care, where the needs of users are complex and require continuous monitoring of subjective and objective indicators of mental state. The aim of this paper is to demonstrate the application of the NP in a person with a chronic mental disorder through a case report.</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Case report: </span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">The research was conducted at the Home for Mentally Ill Persons "1. oktobar" in Stari Lec. The subject is a 61-year-old male patient with a medical diagnosis of <span style="mso-bidi-font-weight: bold;">F20.0 (paranoid schizophrenia)</span>. The patient has been institutionalized since 2013, and the clinical presentation is characterized by auditory hallucinations, rapid thought flow (<span style="mso-bidi-font-weight: bold;">tachypsychia</span>), elevated mood (<span style="mso-bidi-font-weight: bold;">hyperthymia</span>), and increased volitional activity (<span style="mso-bidi-font-weight: bold;">hyperbulia</span>) without the realization of plans. Additionally, sleep disturbance (<span style="mso-bidi-font-weight: bold;">insomnia</span>) and strained family relationships with the father were identified. By applying the NP, seven nursing diagnoses were identified. The care plan included <span style="mso-bidi-font-weight: bold;">15 independent</span> and <span style="mso-bidi-font-weight: bold;">6 interdependent</span> nursing interventions. Key nursing measures included: establishing a therapeutic relationship and trust; continuous monitoring and control of hallucinations; implementing a hygienic-dietary regimen to regulate sleep; guiding the patient during logorrheic speech; providing support in maintaining social contacts with his sons. The evaluation determined partial achievement of goals in terms of behavioral stabilization and better cooperation in self-care activities.</span></p> <p class="MsoNormal" style="margin-bottom: .0001pt; text-align: justify; line-height: 150%;"><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Conclusion: </span></strong><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">The case report confirms that the NP allows for a comprehensive assessment of the patient's needs and a clear definition of the nursing role within a multidisciplinary team. It is essential to implement the NP into mandatory nursing documentation at the national level to ensure the quality, continuity, and legal security in the treatment and care of persons with mental health disorders.</span></p>Ana ŽigićKatarina Pavlović JugovićSlavica LazićVesna R. Jovanović
Copyright (c) 2026 HEALTH CARE
2026-06-222026-06-2255110.5937/zdravzast54-63101